Overexpression of microRNAs miR-25-3p, miR-185-5p and miR-132-3p in Late Onset Fetal Growth Restriction, Validation of Results and Study of the Biochemical Pathways Involved

Autor: Loscalzo G, Scheel J, Ibañez-Cabellos JS, García-Lopez E, Gupta S, García-Gimenez JL, Mena-Mollá S, Perales-Marín A, Morales-Roselló J

Publikováno v: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Banco de España
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

In a prospective study, 48 fetuses were evaluated with Doppler ultrasound after 34 weeks and classified, according to the cerebroplacental ratio (CPR) and estimated fetal weight (EFW), into fetuses with normal growth and fetuses with late-onset fetal

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::58bdd03ff6d61d0f563d1b939568f9c3
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=16442

Overexpression of microRNAs miR-25-3p, miR-185-5p and miR-132-3p in Late Onset Fetal Growth Restriction, Validation of Results and Study of the Biochemical Pathways Involved.

Autor: Loscalzo G; Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.; Department of Obstetrics and Gynecology, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain., Scheel J; Department of Systems Biology and Bioinformatics, University Rostock, 18055 Rostock, Germany., Ibañez-Cabellos JS; EpiDisease S.L, Parc Científic, University of Valencia, 46980 Paterna, Spain.; Consortium Center for Biomedical Network Research on Rare Diseases (CIBERER), Carrer d'Alvaro de Bazan, 10, 46010 Valencia, Spain., García-Lopez E; EpiDisease S.L, Parc Científic, University of Valencia, 46980 Paterna, Spain., Gupta S; Department of Systems Biology and Bioinformatics, University Rostock, 18055 Rostock, Germany., García-Gimenez JL; EpiDisease S.L, Parc Científic, University of Valencia, 46980 Paterna, Spain.; Consortium Center for Biomedical Network Research on Rare Diseases (CIBERER), Carrer d'Alvaro de Bazan, 10, 46010 Valencia, Spain.; Institute of Health Carlos III, Biomedical Research Institute INCLIVA, 46010 Valencia, Spain.; Department of Physiology, School of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain., Mena-Mollá S; EpiDisease S.L, Parc Científic, University of Valencia, 46980 Paterna, Spain.; Institute of Health Carlos III, Biomedical Research Institute INCLIVA, 46010 Valencia, Spain.; Department of Physiology, School of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain., Perales-Marín A; Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.; Department of Obstetrics and Gynecology, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.; Department of Pediatrics, Obstetrics and Gynecology, School of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain., Morales-Roselló J; Instituto de Investigación Sanitaria La Fe, 46026 Valencia, Spain.; Department of Obstetrics and Gynecology, Hospital Universitario y Politécnico La Fe, 46026 Valencia, Spain.; Department of Pediatrics, Obstetrics and Gynecology, School of Medicine and Dentistry, University of Valencia, 46010 Valencia, Spain.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2021 Dec 28; Vol. 23 (1). Date of Electronic Publication: 2021 Dec 28.